A Case of Extensive Alopecia Areata Following Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine with Favorable Outcome

    January 2023 in “ Journal of Cutaneous Immunology and Allergy ”
    Yoshihiro Matsuda, Yoshio Kawakami, Masaya Kawamoto … Shin Morizane
    Studysummary This case report describes a 37-year-old woman who developed widespread hair loss following the BNT162b2 mRNA vaccine, which mostly recovered after topical corticosteroid treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. The Role of SARS-CoV-2 Infection and Its Vaccines in Various Types of Hair Loss Dermatologic Therapy · 2022